The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing cancer and diabetes treatments using live

Total Raised

$34 M

Rounds

2

Links

Verticals

Biotechnology
Clinical Trials
Health Care
Medical
Medical Device

Investment History

  1. Series C

    Aug 2025

    $7M

  2. Equity

    Feb 2014

    $27M

Team

Kenneth Waggoner

Chief Executive Officer, President and General Counsel

Eva Maria Brandtner

Director of Diabetes Program Development

Matthias Lohr

Consultant

Jose Iglesias

Consulting Chief Medical Officer